Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells
Amanda van Vliet, Anna‐Maria Georgoudaki, Ella Peters, Monica Raimo(University of Turin), Daniëlle Steenmans, Susan Gibbs(Academic Center for Dentistry Amsterdam), Adil Doganay Duru(Karolinska University Hospital), Tanja D. de Gruijl(Dutch Cancer Society), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Denise Vodegel
Cited by 9
Related Papers
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
|Radiology|2020|363
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|The Lancet Oncology|2012|357
The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models
|Frontiers in Cell and Developmental Biology|2020|334